Assessment of residual risk of hepatitis C virus transmission by blood transfusion in Taiyuan

Journal Title: Chinese Journal of Blood Transfusion - Year 2022, Vol 35, Issue 8

Abstract

Objective To analyze the epidemic of hepatitis C virus (HCV) in voluntary blood donors , and to assess the residual risk of HCV transmission by blood transfusion in Taiyuan. Methods The HCV screening results of voluntary blood donors in Taiyuan from 2016 to 2021 were collected by blood center information system, and the epidemiologic feature of first-time and repeated donors were analyzed. The incidence-window period model was used to assess the residual risk of HCV transmission by transfusion in first-time/repeated donors as well as that in repeated donors under different blood screening modes. Results Of the 662 705 samples in Taiyuan from 2016 to 2021, the HCV positive rate of the first-time donors was 1.83‰(595/325 009) and the residual risk of HCV transmission was 14.91/100 000. The HCV positive rate of the repeated donors was 0.04‰ (13/337 696) and the residual risk was 0.31/1 000 000. The total residual risk of HCV transmission was 7.47/1 000 000. A total of 337 696 blood samples of repeated blood donors were tested, the repeated blood donors’ residual risk of transfusion-transmitted HCV was 0.31/100 000 after dual ELISA tests , and 0.06/100 000 after dual ELISA and once NAT, which reduce by 80.65% since NAT were adopted. Conclusion The residual risk of HCV transmission from repeated donors was less than that from first-time donors. The blood screening mode of HCV by dual ELISA and once NAT can effectively reduce the residual risk of transfusion-transmitted HCV and improve blood safety. The rate of repeat blood donation needs to be increased by continuously optimizing the recruitment strategy of blood donors.

Authors and Affiliations

Zhiye LI, Yuan ZHOU, Peizhe ZHAO, Baifeng SHAN, Jianying ZHANG, Zhenhua WANG, Bin WANG, Qiang ZHANG

Keywords

Related Articles

Efficacy of three plasma exchange methods in improving renal insufficiency after kidney transplantation and the induction of plasma exchange related adverse reactions: a comparative study

Objective To compare the efficacy of double filtration plasmapheresis(DFPP), centrifugal therapeutic plasma exchange(cTPE) and centrifugation-filtration plasmapheresis(CFPP) in improving renal insufficiency after kidney...

Molecular genetic analysis and predigree of a new FUT1 allele of para-Bombay blood group: a case report

Objective To study the serological and molecular mechanism of a case of para-Bombay blood group caused by 236delG mutation of FUT1 gene and investigate the pedigree. Methods The ABO, H and Lewis antigens of the proband a...

Hemolytic disease of the newborn caused by anti-c in puerperant of Asian-type DEL treated by transfusion: a case report

Objective To explore a transfusion therapeutic plan for hemolytic disease of the newborn(HDN) caused by anti-c antibodies in mother of Asian-type DEL. Methods The ABO blood type and Rh phenotype of the mother and child w...

Binding and carrying role of human serum albumin from various sources to sphingosine-1-phosphate

Objective To investigate the binding and carrying effects of human serum albumin (HSA) from various sources on sphingosine-1-phosphate (S1P). Methods Utilizing human plasma-derived HSA (pHSA) and recombinant HSA (rHSA) s...

Enlightenment from the revision of Standard for Blood Storage

The recently officially approved and released health industry standard Standard for Blood Storage(WS 399-2023) by the National Health Commission is the latest revised version of Standard for Blood Storage(WS 399-2012), w...

Download PDF file
  • EP ID EP738325
  • DOI 10.13303/j.cjbt.issn.1004-549x.2022.08.018
  • Views 23
  • Downloads 0

How To Cite

Zhiye LI, Yuan ZHOU, Peizhe ZHAO, Baifeng SHAN, Jianying ZHANG, Zhenhua WANG, Bin WANG, Qiang ZHANG (2022). Assessment of residual risk of hepatitis C virus transmission by blood transfusion in Taiyuan. Chinese Journal of Blood Transfusion, 35(8), -. https://europub.co.uk/articles/-A-738325